Prospective Investigation of Pulmonary Embolism DX-III

肺栓塞 DX-III 的前瞻性研究

基本信息

  • 批准号:
    7254868
  • 负责人:
  • 金额:
    $ 16.66万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2005
  • 资助国家:
    美国
  • 起止时间:
    2005-08-01 至 2009-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The Prospective Investigation of Pulmonary Embolism Diagnosis in (PIOPED ffl) is a multicenter prospective investigation designed to give a quantitative assessment of the sensitivity and specificity of gadolinium enhanced magnetic resonance angiography (MRA) for the diagnosis of acute pulmonary embolism (PE). The study design is a prospective study of consecutive patients incorporating standardized inclusion/exclusion criteria, complete ascertainment of patient characteristics and outcomes, uniform diagnostic criteria, and unbiased central reading of imaging studies. Over a period of two years, 1256 patients with suspected acute PE will be recruited at 7 clinical centers. All patients will undergo clinically indicated tests to diagnose or exclude PE. This includes a validated clinical assessment, D-dimer by rapid enzyme-linked immunosorbent assay (ELIS A), compression ultrasound of the lower extremities, ventilation/perfusion (V/Q) lung scan, contrast enhanced spiral computed tomography (CT), and ultimately may include pulmonary digital subtraction angiography (DSA). It is expected that 317 patients will have PE and they will undergo gadolinium enhanced MRA. It is expected that 939 patients will be shown to have no PE. From among this group with no PE, 317 patients will be randomized for MRA (and venous ultrasound as well). All MRA images and all images used for the diagnosis or exclusion of PE in patients who had an MRA will be sent for blinded central readings by two readers.
描述(由申请人提供): 肺栓塞诊断的前瞻性研究(PIOPED ffl)是一项多中心前瞻性研究,旨在定量评估钆增强磁共振血管造影(MRA)诊断急性肺栓塞(PE)的敏感性和特异性。研究设计是一项前瞻性研究,纳入了标准化的纳入/排除标准、患者特征和结局的完全确定、统一的诊断标准和无偏倚的影像学研究中心阅读。在两年的时间内,将在7个临床中心招募1256例疑似急性PE患者。所有患者都将接受有临床指征的检查,以诊断或排除PE。这包括经验证的临床评估、通过快速酶联免疫吸附试验(ELISA)进行的D-二聚体、下肢加压超声、通气/灌注(V/Q)肺扫描、对比增强螺旋计算机断层扫描(CT),最终可能包括肺数字减影血管造影(DSA)。预计将有317名患者发生PE,他们将接受钆增强MRA。预计939例患者将显示无PE。在无PE的该组中,317例患者将随机接受MRA(以及静脉超声)。所有MRA图像和用于诊断或排除接受MRA的患者的PE的所有图像将由两名读片员发送进行盲态中心读片。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Pamela K Woodard其他文献

Feasibility of MRI attenuation correction in cardiac FDG-PET
  • DOI:
    10.1186/1532-429x-15-s1-o61
  • 发表时间:
    2013-01-30
  • 期刊:
  • 影响因子:
  • 作者:
    Jeffrey M Lau;Shivak Sharma;Richard Laforest;Jonathan McConathy;James Barnwell;Agus Priatna;Linda M Becker;Glenn J Foster;Robert J Gropler;Pamela K Woodard
  • 通讯作者:
    Pamela K Woodard
1018-148 Assessment of coronary artery stent patency with in-stent contrast enhancement in multirow detector computed tomography angiography
  • DOI:
    10.1016/s0735-1097(04)91326-5
  • 发表时间:
    2004-03-03
  • 期刊:
  • 影响因子:
  • 作者:
    George S Chrysant;Cheng Hong;Pamela K Woodard;John M Lasala;Kyongtae T Bae
  • 通讯作者:
    Kyongtae T Bae

Pamela K Woodard的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Pamela K Woodard', 18)}}的其他基金

Validation of Myocardial Oxygen Extraction Fraction Measurement with MRI
MRI 心肌氧提取分数测量的验证
  • 批准号:
    10735534
  • 财政年份:
    2023
  • 资助金额:
    $ 16.66万
  • 项目类别:
A Receptor-Targeted Nanoparticle PET Tracer in Human Carotid Atherosclerosis
人颈动脉粥样硬化受体靶向纳米粒子 PET 示踪剂
  • 批准号:
    10671549
  • 财政年份:
    2022
  • 资助金额:
    $ 16.66万
  • 项目类别:
Prospective Investigation of Pulmonary Embolism DX-III
肺栓塞 DX-III 的前瞻性研究
  • 批准号:
    6956977
  • 财政年份:
    2005
  • 资助金额:
    $ 16.66万
  • 项目类别:
Prospective Investigation of Pulmonary Embolism DX-III
肺栓塞 DX-III 的前瞻性研究
  • 批准号:
    7500092
  • 财政年份:
    2005
  • 资助金额:
    $ 16.66万
  • 项目类别:
Prospective Investigation of Pulmonary Embolism DX-III
肺栓塞 DX-III 的前瞻性研究
  • 批准号:
    7104858
  • 财政年份:
    2005
  • 资助金额:
    $ 16.66万
  • 项目类别:
PROSPECTIVE INVESTIGATION OF PULMONARY EMBOLISM DX-II
肺栓塞 DX-II 的前瞻性研究
  • 批准号:
    6167699
  • 财政年份:
    2000
  • 资助金额:
    $ 16.66万
  • 项目类别:
PROSPECTIVE INVESTIGATION OF PULMONARY EMBOLISM DX-II
肺栓塞 DX-II 的前瞻性研究
  • 批准号:
    6527264
  • 财政年份:
    2000
  • 资助金额:
    $ 16.66万
  • 项目类别:
PROSPECTIVE INVESTIGATION OF PULMONARY EMBOLISM DX-II
肺栓塞 DX-II 的前瞻性研究
  • 批准号:
    6659858
  • 财政年份:
    2000
  • 资助金额:
    $ 16.66万
  • 项目类别:

相似海外基金

De-Adoption Beta-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a randomized Trial with blinded Endpoints (ABbreviate)
在没有左心室射血分数降低、持续性缺血或心律失常的稳定型缺血性心脏病患者中停用β受体阻滞剂:一项盲法终点随机试验(ABbreviate)
  • 批准号:
    481560
  • 财政年份:
    2023
  • 资助金额:
    $ 16.66万
  • 项目类别:
    Operating Grants
The effectiveness of oral cannabis extracts for osteoarthritic pain: an internal pilot, placebo controlled, blinded randomized trial
口服大麻提取物对骨关节炎疼痛的有效性:一项内部试点、安慰剂对照、盲法随机试验
  • 批准号:
    479511
  • 财政年份:
    2023
  • 资助金额:
    $ 16.66万
  • 项目类别:
    Operating Grants
IMPACT, a supervised rehabilitation program for spastic ataxias: A rater-blinded, randomized controlled trial
IMPACT,痉挛性共济失调的监督康复计划:一项评估者盲法、随机对照试验
  • 批准号:
    468464
  • 财政年份:
    2022
  • 资助金额:
    $ 16.66万
  • 项目类别:
    Operating Grants
Lineup construction methods: Should lineup constructors be blinded to the suspect?
阵容构建方法:阵容构建者是否应该对嫌疑人视而不见?
  • 批准号:
    2754233
  • 财政年份:
    2022
  • 资助金额:
    $ 16.66万
  • 项目类别:
    Studentship
ZZ-3K3A-301: A multicenter, randomized, placebo-controlled, double-blinded, Phase 3 study to evaluate the efficacy and safety of 3K3A-APC (RHAPSODY-2)
ZZ-3K3A-301:一项多中心、随机、安慰剂对照、双盲、3 期研究,旨在评估 3K3A-APC (RHAPSODY-2) 的有效性和安全性
  • 批准号:
    10305528
  • 财政年份:
    2022
  • 资助金额:
    $ 16.66万
  • 项目类别:
Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Vortioxetine for Cognitive Deficits in Persons with Post-COVID-19 Condition
评估沃替西汀对 COVID-19 后患者认知缺陷的随机、双盲、安慰剂对照研究
  • 批准号:
    467059
  • 财政年份:
    2021
  • 资助金额:
    $ 16.66万
  • 项目类别:
    Studentship Programs
Blinded Comparison of Different Alpha-Synuclein Seeding Assays as Cutaneous Biomarkers of Lewy Body Dementias
不同 α-突触核蛋白接种测定作为路易体痴呆皮肤生物标志物的盲法比较
  • 批准号:
    10458459
  • 财政年份:
    2021
  • 资助金额:
    $ 16.66万
  • 项目类别:
Blinded Comparison of Different Alpha-Synuclein Seeding Assays as Cutaneous Biomarkers of Lewy Body Dementias
不同 α-突触核蛋白接种测定作为路易体痴呆皮肤生物标志物的盲法比较
  • 批准号:
    10674759
  • 财政年份:
    2021
  • 资助金额:
    $ 16.66万
  • 项目类别:
Blinded Comparison of Different Alpha-Synuclein Seeding Assays as Cutaneous Biomarkers of Lewy Body Dementias
不同 α-突触核蛋白接种测定作为路易体痴呆皮肤生物标志物的盲法比较
  • 批准号:
    10064563
  • 财政年份:
    2021
  • 资助金额:
    $ 16.66万
  • 项目类别:
Discontinuation of levothyroxine therapy for patients with subclinical hypothyroidism: a pilot randomized, double-blinded, placebo-controlled study
亚临床甲状腺功能减退症患者停止左旋甲状腺素治疗:一项随机、双盲、安慰剂对照试验研究
  • 批准号:
    10184448
  • 财政年份:
    2021
  • 资助金额:
    $ 16.66万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了